Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
BOSTON – Rohit Kulkarni, M.D., Ph.D., senior investigator in the Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center and associate professor at Harvard Medical School, coauthored a paper that was published today in Diabetes, which voiced concerns about the increasing difficulty of access to high quality islet cells for diabetes research.
Andrew Stewart, M.D., Director of the Diabetes, Obesity and Metabolism Institute at Mount Sinai Hospital in New York, served as the other lead author.
“Obtaining human islets for research in diabetes is an important component that will allow investigators to gain critical insights into how insulin-producing cells work,” says Kulkarni. “These experiments are of high significance in the overall goal of developing therapeutic approaches to successfully replace and/or regenerate insulin-producing cells in all forms of human diabetes.”
http://www.uofmhealth.org/news/arch...se-alarm-shortage-human-islet-cells-will-slow
Andrew Stewart, M.D., Director of the Diabetes, Obesity and Metabolism Institute at Mount Sinai Hospital in New York, served as the other lead author.
“Obtaining human islets for research in diabetes is an important component that will allow investigators to gain critical insights into how insulin-producing cells work,” says Kulkarni. “These experiments are of high significance in the overall goal of developing therapeutic approaches to successfully replace and/or regenerate insulin-producing cells in all forms of human diabetes.”
http://www.uofmhealth.org/news/arch...se-alarm-shortage-human-islet-cells-will-slow